Luhua Wang Selected Research

Luhua Wang Research Topics

Disease

54	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 04/2006
30	Neoplasms (Cancer) 01/2024 - 12/2008
14	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2006
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 04/2006
11	Pneumonia (Pneumonitis) 01/2023 - 08/2010
7	Radiation Pneumonitis 03/2024 - 01/2007
7	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2011
6	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 01/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 04/2006
5	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2012
5	Esophageal Squamous Cell Carcinoma 01/2022 - 05/2013
5	Carcinoma (Carcinomatosis) 02/2021 - 12/2008
3	Disease Progression 01/2022 - 03/2016
3	Adenocarcinoma of Lung 01/2021 - 06/2015
3	Adenocarcinoma 12/2016 - 04/2006
2	Esophagitis 10/2023 - 02/2023
2	Hypoxia (Hypoxemia) 01/2023 - 01/2021
2	Carcinogenesis 10/2022 - 01/2022
2	Margins of Excision 01/2021 - 12/2013
2	Adenoid Cystic Carcinoma (Cylindroma) 01/2021 - 12/2018
2	Thymoma (Thymic Carcinoma) 01/2020 - 08/2013
2	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2011 - 08/2010
1	Fibrosis (Cirrhosis) 01/2023
1	Pulmonary Alveolar Proteinosis 01/2023
1	Carcinosarcoma 10/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Lung Injury 02/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Cough 01/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Heart Failure 01/2021
1	Pulmonary Hypertension 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021
1	Circulating Neoplastic Cells 01/2020
1	Tics (Tic) 07/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2013
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2010
5	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2020
5	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2014
5	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 05/2010
3	B7-H1 AntigenIBA 01/2023 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2010 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 06/2013
2	thiamine triphosphorate (TTP)IBA 01/2022 - 04/2006
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
2	durvalumabIBA 01/2022 - 01/2022
2	endostar proteinIBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
2	nimotuzumabIBA 02/2021 - 01/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2013
2	Pemetrexed (MTA)FDA Link 01/2021 - 12/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2019 - 04/2010
2	Tumor Biomarkers (Tumor Markers)IBA 08/2018 - 06/2014
1	LipidsIBA 01/2024
1	Circulating Tumor DNAIBA 12/2023
1	InterferonsIBA 01/2023
1	toripalimabIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 10/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022
1	olaparibIBA 01/2022
1	Essential Amino AcidsIBA 01/2022
1	CI 22IBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	EndostatinsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	KynurenineIBA 01/2022
1	GoldIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 02/2021
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Gefitinib (Iressa)FDA Link 06/2020
1	Celecoxib (Celebrex)FDA Link 12/2019
1	DiamondIBA 07/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	LigandsIBA 01/2019

Therapy/Procedure

60	Radiotherapy 05/2024 - 04/2006
19	Chemoradiotherapy 01/2024 - 01/2010
15	Drug Therapy (Chemotherapy) 03/2024 - 01/2007
15	Therapeutics 01/2024 - 12/2013
5	Immunotherapy 01/2024 - 01/2019
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2022 - 12/2016
4	Adjuvant Chemotherapy 08/2021 - 01/2014
2	Conformal Radiotherapy 12/2016 - 01/2013
2	Consolidation Chemotherapy 12/2016 - 10/2015
2	Adjuvant Radiotherapy 12/2013 - 08/2013
1	Photothermal Therapy 01/2022
1	Cranial Irradiation 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Pneumonectomy (Lung Volume Reduction) 05/2019
1	Neoadjuvant Therapy 01/2019